The Medical Genomics Laboratory (MGL) is a CAP-certified nonprofit clinical laboratory at the University of Alabama at Birmingham, offering comprehensive testing for common and rare genetic disorders. The MGL specializes in testing for all forms of the neurofibromatoses including NF1, Legius syndrome (SPRED1 disorder), segmental NF, NF-Noonan, spinal NF, Watson syndrome, NF2, and schwannomatosis as well as the RASopathies, and tuberous sclerosis complex.
The Medical Genomics Laboratory is pleased to offer new next generation sequencing testing options for NF1/SPRED1 and other Rasopathy related conditions.
For more information, click here.
For additional testing details, click here.
UAB researchers work to unravel the complex genetic disease neurofibromatosis type 1
Click here to find a recent article regarding the ongoing research in the neurofibromatoses taking place in the Medical Genomics Laboratory.
The Medical Genomics Laboratory recently published a genotype-phenotype correlation identified in a large cohort of patients carrying missense mutations affecting NF1 codon 1809.
Click here for a summary of the findings and a link to article.
Ludwine Messiaen, Ph.D., FACMG, Director
Alicia Gomes, MS, CGC, Genetic Counselor
Angela Sharp, MMedSc, Diagnostic Coordinator
Anne Meadows, CPC, Billing Coordinator
Erin Murphy-Baum, MS, Lab Manager
Sheila Walton, Office Associate
Latoya Conner, Office Associate
UAB Medical Genomics Laboratory
720 20th St. S., Suite 330
Birmingham, AL 35294
Tell us how we are doing! Please complete our customer satisfaction survey and share your feedback! Please click here for survey.